News

All told, Super Micro Computer stock offers a PEG of only 0.6x today, meaning that roughly 40% of the company’s future expected EPS growth has yet to be priced into today’s valuation metrics. This ...
The Wall Street consensus for Cleveland-Cliffs stock is a Hold, targeting the company’s value at only $10.9 per share, or 4.5% additional upside. However, this may not reflect the stock’s true ...
Investing.com -- Immuneering Corp (NASDAQ:IMRX) stock surged 21.7% Monday after the clinical-stage oncology company announced ...
The Fed Chair sent stocks higher after his dovish tone on rates at Jackson Hole. Stocks finished last week strong, fueled by what investors viewed as a dovish speech by Fed Chair Jerome Powell on ...
S&P forecasts that Metsa Board’s adjusted EBITDA in 2025 will drop to €65 million-€75 million, down from €163 million in 2024 and well below the previous forecast of €212 million.
Investing.com -- Fitch Ratings has upgraded Newmark ’s commercial primary servicer rating to ’CPS2+’ from ’CPS2’ while affirming its commercial special servicer rating at ’CSS3+’, the rating agency ...
The negative outlook reflects Moody’s expectation that Wesco’s debt-to-EBITDA ratio will remain elevated, with revenue projected to decline in the low single digits in 2025 due to weakness in the ...
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...
Investing.com--The U.S. dollar jumped Monday, but further gains are likely to prove challenging particularly against major ...
WASHINGTON (Reuters) -The U.S. Justice Department on Monday indicated it would appeal a judge’s ruling barring Alina Habba, a ...
Daniel Roberts, Co-Founder and Co-CEO of Iris Energy, stated that the expanded Blackwell capacity positions the company to capture strong demand and drive the next phase of its AI Cloud revenue growth ...
Investing.com -- Atai Life Sciences (NASDAQ:ATAI) stock rose 6.2% after AbbVie (NYSE:ABBV) announced plans to acquire ...